Side Effect Management

Caroline Taylor discusses how disparities in access and resources affect diagnosis, treatment, and survival for patients globally.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.

The FDA accepted an investigational new drug application for chemo-related neuropathy, advancing a potential non-opioid treatment into a clinical trial.

Early detection and grade-based care help manage immunotherapy toxicities, with tailored approaches for skin, gastrointestinal and cardiac side effects.

Topical HT-001 reduced rash and irritation from EGFR therapies with low levels in the bloodstream and no serious side effects in patients with cancer.

A structured exercise program may reduce cognitive decline, often referred to as “chemo brain,” in patients receiving chemotherapy for the first time.

Ipsen has pulled Tazverik from all markets after a trial found risks of secondary blood cancers, affecting patients with follicular lymphoma and epithelioid sarcoma.

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions.

Dr. Brittany Dulmage explains how biotin can interfere with lab testing and discusses safer, evidence-based options for managing cancer-related hair loss.

I share how choosing what to do with my hair during treatment helped me reclaim control and redefine empowerment.

As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so severe that she was unable to walk.

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

CURE spoke with experts about possible side effects faced by patients with breast cancer.

After decades of lymphedema, breast cancer survivor Nora Ambros finds relief through robot-assisted microsurgery at Hackensack University.

Heather Ann Yonker expands on strategies for maintaining food safety in the home, particularly for patients with compromised immune systems due to cancer.

Napo Pharmaceuticals applied for orphan drug designation for Mytesi to treat diarrhea in patients with breast cancer and brain metastases on targeted therapy.

An LED-based intraoral device was safe and reduced severe oral mucositis and throat pain in patients receiving radiotherapy for head and neck cancers.

The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

Existing autoimmune drugs may prevent or reverse a serious side effect faced by patients with cancer.

CURE spoke with an expert to learn what patients need to know about immunotherapy-induced diabetes.

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

Summer heat can worsen my lymphedema, but I’ve learned simple ways to stay cool, reduce swelling and protect my arms — here’s what helps me most.

New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.

Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.

Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.

Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.